Re: “Palliative Care in Europe: Safeguarding Compassion Amidst Changing End‐Of‐Life Policies and Expanding Access to Medically Assisted Dying Position Statement on Behalf of the European Academy of Neurology, the European Federation of Neurological Associations and OneNeurology” by Rukavina Et al. Authors: Eugenio Pucci, Alessandra Solari, Gianluigi Mancardi, Leandro Provinciali, Nicola Ticozzi, Alessandro Padovani Published: 2026 Dear Editor, We read with interest the position statement by Rukavina and colleagues [1], which emphasizes that access to early, high‐quality and integrated palliative care (PC) must remain an accessible option for people living with long‐term neurological conditions (LTNC), irrespective of evolving legislation on medically assisted dying (MAD). We share this position. We would like to extend the discussion by considering a question of particular relevance to neurological practice that is how neurologists should respond when a competent patient continues to request MAD despite receiving appropriate and comprehensive care, including PC. This question cannot have a uniform European answer. Legal frameworks differ substantially across countries, and decisions concerning the permissibility and regulation of MAD remain within national legal and societal contexts. In Italy, for example, in the absence of specific legislation, Constitutional Court Judgment no. 242/2019 identified a narrow area of non‐punishability for assisted suicide under defined conditions, including decisional capacity and dependence on life‐sustaining treatment. Such differences reinforce, rather than diminish, the need for neurologists to understand the clinical and ethical issues raised by these requests [2]. We acknowledge that individuals living with LTNC present multiple complexities. Cognitive impairment, communication difficulties, fluctuating symptoms, severe physical disability, and uncertain prognosis may complicate assessment of decisional capacity. Suffering itself may encompass physical, psychological, social, and existential dimensions. At the same time, vulnerability or disability should not in themselves be interpreted as evidence of impaired autonomy. Careful individualized assessment is therefore essential, ideally within a multidisciplinary framework. PC has a fundamental role in this process. It may relieve suffering, improve quality of life, and, in some patients, modify wishes concerning end‐of‐life decisions. However, even optimal PC does not remove every persistent request for MAD. Recognizing this does not place PC and MAD in opposition, nor does it imply that MAD should compensate for inadequate access to care. We therefore agree with Rukavina et al. [1] that neurologists require education in PC and advance care planning. We suggest that such education should also include how to recognize, explore, and manage requests for MAD, including assessment of capacity, potentially reversible causes of suffering, prognosis, and voluntariness, as well as knowledge of the applicable legal framework. This competence is relevant even where MAD is not legally available. European neurological organizations cannot replace national societies or legislators in determining end‐of‐life policy. They should, however, provide a common clinical and ethical framework, promote education, and support rigorous evidence‐based discussion across different legal systems. This may ultimately be one of the most useful contributions of neurology to an increasingly complex and evolving area of care. Author Contributions Eugenio Pucci: conceptualization, writing – original draft, supervision, writing – review and editing. Alessandra Solari: writing – original draft, writing – review and editing, supervision. Gianluigi Mancardi: writing – review and editing. Leandro Provinciali: writing – review and editing. Nicola Ticozzi: writing – review and editing. Alessandro Padovani: writing – original draft, writing – review and editing, supervision. Conflicts of Interest E.P. declared that “Associazione Marchigiana Sclerosi Multipla e altre malattie neurologiche‐ETS” provided organizational support. The other authors declared no conflicts of interest that are relevant to the content of this letter. Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analysed during the current study. References Associated Data Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analysed during the current study.